650-263-7636 contact@endothelix.com

The Vascular Endothelial Barrier: A Novel Therapeutic Target for Preventing Atrial Fibrillation (View Abstract)

P705 – The Vascular Endothelial Barrier: A Novel Therapeutic Target for Preventing Atrial Fibrillation View Abstract

Scientific Updates Sponsored by Endothelix Inc.

On November 30, 2020 / Scientific Updates

Microvascular Dysfunction in Peripheral Artery Disease: Is Heat Therapy a Viable Treatment?
Int J Environ Res Public Health 2021 Mar 1;18(5):2384. Microvascular Dysfunction in Peripheral...
Will these new iRNA-based LDL and Lp(a) Lowering Rx Make a Significant Impact on US’ Average Cholesterol Level? Probably Not.
J Am Coll Cardiol. 2021 Mar, 77 (12) 1564–1575 New and Emerging Therapies for Reduction...
Diastolic Dysfunction vs. Endothelial Dysfunction
Eur J Clin Invest 2021 Mar 22 Clinical assessment of endothelial function in...
Brain Endothelium in Health and Disease
Am J Pathol 2021 Mar 10 ENDOTHELIAL CONTROL OF CEREBRAL BLOOD FLOW Julianne...
New noninvasive approaches to the endothelium as a therapeutic target
Front Physiol 2021 . The Endothelium as a Therapeutic Target in Diabetes: A...
New insights into the role of INF in “hyperinflammation”, endothelial injury, and two different COVID outcomes
Transl Res 2021 Mar 5;S1931-5244(21)00052-9. COVID-19 and Cytokine Storm Syndrome: Are there lessons...
Why Is COVID-19 More Severe in Patients With Diabetes?
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting...
How to use endothelial function testing to detect “Residual Risk”
Practical Guidelines for Endothelial Function Testing in Primary Prevention and Detecting “Residual Risk”...